Category: Investigations

Live Ventures Inc. (LIVE) Made Misleading Statements Regarding its Business, Operations, and Prospects     Between December 28, 2016 and August 3, 2021, defendants made materially

CorMedix Inc. (CRMD) Failed to Disclose Deficiencies in the Manufacturing Process of its Lead Product Candidate CorMedix completed submission of a New Drug Application (“NDA”)

SelectQuote, Inc. (SLQT) Failed to Disclose Underperformance of its PDP Products     Between February 8, 2021 and May 11, 2021, SelectQuote failed to disclose to

loanDepot, Inc. (LDI) Materially Misrepresented its Business Prospects in Connection with its IPO loanDepot, Inc. held its initial public offering (“IPO”) on February 16, 2021.

Concho Resources Inc. (CXO) Misled the Investing Public Regarding Optimum Well Spacing and its Ability to Take on Large-Scale Projects   In 2018, Concho constructed

Spectrum Pharmaceuticals, Inc. (SPPI) Materially Misrepresented the Likelihood ROLONTIS Would be Approved by the FDA Spectrum submitted a Biologics License Application (“BLA”) to the U.S.

Cassava Sciences, Inc. (SAVA) Falsely Touted the Viability and Efficacy of its Lead Drug Candidate     On February 2, 2021, Cassava announced results from its

HyreCar Inc. (HYRE) Materially Misstated its Insurance Reserves     On May 13, 2021, HyreCar announced “Record First Quarter 2021 Financial Result,” stating that insurance deposits

Cassava Sciences, Inc. (SAVA) Falsely Touted the Viability and Efficacy of its Lead Drug Candidate     On February 2, 2021, Cassava announced results from its